While suppressed glycolysis were found in placenta of pregnant women with hyperglycemia (Valent et al. 2021), suggesting that CAMK4 overexpression may be beneficial for glycometabolism regulation although its effectiveness and safety needed to be confirmed in experimental GDM animals. The gene discussed is CAMK4; the disease is Hyperglycemia.